Supply of Diphenhydramine Hydrochloride Injection (Pharmaceutical Product)

The contract pertains to the procurement and delivery of one package of sterile Diphenhydramine Hydrochloride Injection, a pharmaceutical product required for military medical use. The product must fully comply with FDA current Good Manufacturing Practices (cGMP) to ensure safety, potency, and consistency, reflecting the stringent quality standards mandated for defense healthcare applications. The supply is being managed under a subcontract arrangement by the Defense Logistics Agency on behalf of the Department of Defense, with the North American Industry Classification System code 325412 indicating the manufacturing of pharmaceutical preparations. Delivery will fulfill a specific operational need within the military medical supply chain, though the exact place of performance and point of contact are not specified in the provided data. The contract was posted on August 9, 2026, and is identified by the contract number SPE2DX25D9900 with delivery order SPE2DP26F8855, indicating it is part of a larger procurement framework. The product’s sterile nature and regulatory compliance underscore its critical role in emergency or field medical scenarios where reliable, ready-to-use medications are essential. There is no mention of set-aside provisions, suggesting this opportunity is open to all qualified vendors meeting the technical and quality requirements.